System C is close to completion on its £200m five-year investment programme in the Medway EPR, a patient management and electronic patient record system designed and built specifically for the NHS. The company is preparing for the nationwide launch of CareFlow EPR at three virtual events in February, March, and April 2022, with live demonstrations and learnings from those pioneering the use of the new system.
The game, out today on iOS and Android and available in English, Spanish, Catalan and Italian, is the result of a two-and-a-half-year long citizen science project developed by a team of researchers at the Centre for Genomic Regulation (CRG), the Centro Nacional de Análisis Genómico (CNAG-CRG) and game professionals.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry's first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company's cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.
A leading global healthcare system, Cleveland Clinic, has launched a landmark study to better understand why millions of people around the world suffer from brain diseases, with the goal of pinpointing disease biomarkers early, well before clinical symptoms present themselves.
Huma has bought iPLATO Healthcare, whose patient engagement software covers a network of 26.6m patients across nearly 3,000 NHS primary care organisations and whose myGP app is one of the most downloaded medical apps in the UK. The two companies will continue to operate independently but will combine their expertise to enable more proactive, predictive and personalised care for patients in a joined-up service across primary and secondary care.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced physicians will now have access to advanced new 3D image guidance capabilities through its Image-Guided Therapy Mobile C-arm System - Zenition, delivering enhanced clinical accuracy and efficiency, and aiming to improve the outcomes for patients undergoing endovascular treatment.